HTGM - HTG Molecular Diagnostics' (HTGM) CEO John Lubniewski on Q3 2021 Results - Earnings Call Transcript

HTG Molecular Diagnostics, Inc. (HTGM) Q3 2021 Earnings Conference Call November 10, 2021 4:30 PM ET Company Participants Monique Kosse – LifeSci Advisors, LLC John Lubniewski – Chief Executive Officer Shaun McMeans – Chief Financial Officer Conference Call Participants Rick Miller – Cantor Fitzgerald Connor Stevenson – Craig-Hallum Presentation Operator Greetings, and welcome to the HTG Molecular Diagnostics, Inc. Third Quarter 2021 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Ms. Monique Kosse of LifeSci Advisors. Thank you. Please go ahead. Monique Kosse Thank you, operator. Earlier today, HTG released its financial results for the third quarter ended September 30, 2021. Before we begin the call, let me remind you that the company's remarks include forward-looking statements within

For further details see:

HTG Molecular Diagnostics' (HTGM) CEO John Lubniewski on Q3 2021 Results - Earnings Call Transcript